U.S. pharma giant copyright scrapped two experimental weight loss capsules previous year—a as soon as-everyday tablet, lotiglipron, because of elevated liver enzymes and a 2 times-each day pill, danuglipron, on account of powerful Uncomfortable side effects—but CEO Albert Bourla has